section name header

Evidence summaries

Surgical Treatment of Tubal Disease in Women Due to Undergo in Assisted Reproductive Technology

Laparoscopic salpingectomy prior to assisted reproductive technology increases pregnancy rate in women with hydrosalpinges compared with no surgery. Level of evidence: "A"

A Cochrane review [Abstract] 1 included 11 studies with a total of 1386 subjects. Laparoscopic salpingectomy increased clinical pregnancy rate (CPR) (RR 2.02, 95% CI 1.44 to 2.82; 4 RCTs; n = 455; I² = 42.5%). This suggests that in women with a CPR of approximately 19% without tubal surgery, the rate with salpingectomy lies between 27% and 52%. Tubal occlusion increased CPR compared to no tubal surgery (RR 3.21, 95% CI 1.72 to 5.99; 2 RCTs; n = 209). Laparoscopic occlusion of the fallopian tube versus no intervention increased CPR (RR 3.21, 95% CI 1.72 to 5.99; 2 RCTs; n = 209; I² = 0%). This suggests that with a CPR of approximately 12% without tubal surgery, the rate with tubal occlusion lies between 21% and 74%. Comparison of tubal occlusion to salpingectomy did not show a significant advantage of either surgical procedure in terms of CPR or live birth rate.

A seven-year real-world retrospective cohort study 2 included 160 women with primary or secondary infertility and laparoscopically confirmed hydrosalpinx, who underwent Palmer-type neosalpingostomy. Clinical pregnancy rate was 33.8%, intrauterine/live birth rate 25.6%, miscarriage rate 3.8%, and ectopic pregnancy rate 4.4%. Recurrence occurred in 21.2% of cases. Outcomes were strongly influenced by hydrosalpinx severity and pelvic adhesions: women with mild disease achieved the highest pregnancy rates. Neither age, AMH, nor laterality were independent predictors. Median time to pregnancy was 9 months.

A network meta-analysis 3 compared the safety and effectiveness of different methods, both ablative and non-ablative, to treat hydrosalpinx in infertile patients before in-vitro fertilization. 9 RCTs revealed no significant differences in live birth rate between hydrosalpinx treatment methods, with laparoscopic tuval occlusion achieving the highest SUCRA value (0.9). Salpingectomy and ultrasound-guided aspiration significantly increased the ongoing pregnancy rate compared with no treatment (OR 4.35 [95% CI 1.70 to 11.14] and 2.80 [95% CI 1.03 to 7.58], respectively), with salpingectomy having the highest SUCRA value (0.9). Clinical pregnancy rate was significantly higher following salpingectomy (OR 2.24 [95% CI 1.30 to3.86]) and laparoscopic tuval occlusion (OR 2.55 [95% CI 1.20 to 5.51]) compared with no treatment.

    References

    • Melo P, Georgiou EX, Johnson N et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2020;(10):CD002125. [PubMed]
    • Barbu LA, Mărgăritescu ND, Cercelaru L, et al. Long-Term Reproductive Outcomes After Palmer-Type Neosalpingostomy in Hydrosalpinx: A Seven-Year Real-World Cohort Study. J Clin Med 2025;14(22):[PubMed]
    • Pérez-Milán F, Caballero-Campo M, Carrera-Roig M, et al. Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis. Ultrasound Obstet Gynecol 2025;65(4):414-426.[PubMed]

Primary/Secondary Keywords